Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma.

Ding, Xinjing; Ding, Jianghua; Gu, Hong; Zhong, Chuanxiang

Ding, Xinjing; Ding, Jianghua; Gu, Hong; Zhong, Chuanxiang.

Afiliación

Ding X; Department of Undergraduate, The Medical College of Nanchang University, Nanchang, Jiangxi Province, China.
Ding J; Department of Hematology & Oncology, The Affiliated Hospital of Jiujiang University, No. 57#, Xunyang East Road, Jiujiang, Jiujiang City, Jiangxi Province, China. doctor0922@126.com.
Gu H; Department of Hematology & Oncology, The People Hospital of Ruichang, Ruichang, Jiangxi Province, China.
Zhong C; Department of Hematology & Oncology, The No. 171 Hospital of PLA, Jiujiang, Jiangxi Province, China.

Support Care Cancer ; 30(5): 4049-4054, 2022 May.

Article en En | MEDLINE | ID: mdl-35064823

Asunto(s)

Mieloma Múltiple; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Bortezomib; Factor Estimulante de Colonias de Granulocitos/uso terapéutico; Humanos; Lenalidomida/uso terapéutico; Mieloma Múltiple/tratamiento farmacológico; Estudios Prospectivos

Palabras clave

Early infection; Long-acting G-CSF; Newly diagnosed multiple myeloma; Primary prophylaxis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google